NCT00714064View on ClinicalTrials.gov

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers

PHASE3CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

July 31, 2011

Conditions
Middle Ear EffusionTympanic Membrane PerforationAcute Otitis MediaPneumococcal Infections
Interventions
BIOLOGICAL

23vPPV, dTpa (Pneumovax, Boostrix)

Group A will receive 23vPPV during 3rd trimester and dTpa at delivery

BIOLOGICAL

23vPPV, dTpa (Pneumovax, Boostrix)

Group B will receive 23vPPV at delivery and dTpa 7 months following delivery

BIOLOGICAL

23vPPV, dTpa (Pneumovax, Boostrix)

Group C will receive dTpa at delivery and 23vPPV 7 months following delivery

Trial Locations (1)

0811

Menzies School of Health Research, Darwin

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

lead

Menzies School of Health Research

OTHER

NCT00714064 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers | Biotech Hunter | Biotech Hunter